Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Pediatr Endocrinol Metab ; 11 Suppl 3: 811-6, 1998.
Article in English | MEDLINE | ID: mdl-10091151

ABSTRACT

Short stature and short trunk have been reported in thalassaemic patients. We report a study on stature and body proportions in 476 patients (2-36 years old) with beta-thalassaemia major, followed in 12 Italian centres. Auxological data (standing height, sitting height, subischial leg length, target height), haematological data (age at first transfusion, age at start of desferrioxamine [DFX] chelation, mean dose of DFX, ferritin values) and information regarding the presence of endocrine disorders and of bone lesions, were collected and analysed according to the age of the patients, in order to investigate the natural history of the disproportion and the role of siderosis, DFX toxicity and endocrine disorders. Our data indicate that about 18% of thalassaemic patients exhibit short stature; disproportion between the upper and lower body segments is present in 14%; however, a short trunk despite normal stature is present in another 40% of patients. This is due to a spinal growth impairment which starts in infancy and progressively aggravates. We think that a short trunk is peculiar to the disease itself; however, other factors such as hypogonadism, siderosis, or DFX-induced bone dysplasia are probably involved in aggravating the body disproportion in these patients.


Subject(s)
Body Constitution , Body Height , beta-Thalassemia/physiopathology , Adolescent , Adult , Aging , Blood Transfusion , Child , Child, Preschool , Deferoxamine/therapeutic use , Female , Ferritins/blood , Humans , Iron Chelating Agents/therapeutic use , Male , beta-Thalassemia/therapy
2.
J Pediatr Endocrinol Metab ; 11 Suppl 3: 965-71, 1998.
Article in English | MEDLINE | ID: mdl-10091174

ABSTRACT

We present data of a detailed study of endocrine function in 50 patients (21 males, 29 females) with thalassaemia intermedia, 15-46 years old (mean age 28.7 yr), with raised serum ferritin levels (mean 1540 micrograms/l). Mean haemoglobin concentration was 8.1 g/dl. Half of them had had more than 50 transfusions in their life and had received irregular intramuscular or subcutaneous chelation therapy. Delayed puberty was one of the most frequent (36%) clinical endocrine abnormalities found in our patients. Primary amenorrhea was observed in two patients and secondary amenorrhea in four patients. Two males, aged 19 and 36 years, had hypogonadism. A poor response to GnRH, found in three females and in both males tested, suggested that pituitary dysfunction was wholly or partially responsible for hypogonadism. Gonadal function was normal in all patients studied. Glucose intolerance and primary hypothyroidism were less frequent (24 and 5.7%, respectively) and milder than in thalassaemia major patients. Two patients had low T3 and T4 and normal basal and stimulated response of TSH to TRH. This condition has been found in euthyroid sick syndrome and it is likely that it represents an adaptive response by the body to minimize catabolism when undergoing major stress. As a consequence, we believe that periodic endocrine evaluation should be carried out in subjects with beta-thalassaemia intermedia, particularly in those over 14 years old, in order to detect and to treat endocrine dysfunction.


Subject(s)
Body Height , Endocrine Glands/physiopathology , beta-Thalassemia/physiopathology , Adolescent , Adult , Amenorrhea/etiology , Blood Transfusion , Chelating Agents/therapeutic use , Female , Glucose Intolerance/etiology , Humans , Hypogonadism/etiology , Hypothyroidism/etiology , Male , Middle Aged , Puberty, Delayed/etiology , beta-Thalassemia/complications , beta-Thalassemia/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...